tiprankstipranks
Advertisement
Advertisement

PCINSIL Stock Latest News

Insilico Advances AI-Designed Ocular Drug ISM9077 as Preclinical Candidate
Private CompaniesInsilico Advances AI-Designed Ocular Drug ISM9077 as Preclinical Candidate
4h ago
INSIL
Insilico Medicine Highlights Automation Tools for PROTAC Linker Design
PremiumPrivate Companies
Insilico Medicine Highlights Automation Tools for PROTAC Linker Design
5h ago
INSIL
Insilico Medicine Highlights Role of Generative AI and China’s Biotech Sector in Drug Discovery
PremiumPrivate Companies
Insilico Medicine Highlights Role of Generative AI and China’s Biotech Sector in Drug Discovery
5h ago
INSIL
Insilico Medicine Showcases Frontier AI Strategy in Drug Discovery and Longevity
PremiumPrivate Companies
Insilico Medicine Showcases Frontier AI Strategy in Drug Discovery and Longevity
5h ago
INSIL
Insilico Medicine Highlighted in Forbes Coverage of Generative Biology at Ai4 2026
PremiumPrivate Companies
Insilico Medicine Highlighted in Forbes Coverage of Generative Biology at Ai4 2026
5h ago
INSIL
Insilico Medicine Highlights AI-Driven Tools for PROTAC Linker Design
PremiumPrivate CompaniesInsilico Medicine Highlights AI-Driven Tools for PROTAC Linker Design
15h ago
INSIL
Insilico Medicine Highlights Role of Generative AI and China in Drug Discovery
Premium
Private Companies
Insilico Medicine Highlights Role of Generative AI and China in Drug Discovery
15h ago
INSIL
AI-Driven Oncology Research Highlights Potential Rare Cancer Targets
Premium
Private Companies
AI-Driven Oncology Research Highlights Potential Rare Cancer Targets
1d ago
INSIL
AI Benchmarks Initiative Highlights Insilico Medicine’s Push in Drug Discovery
PremiumPrivate Companies
AI Benchmarks Initiative Highlights Insilico Medicine’s Push in Drug Discovery
1d ago
INSIL
Insilico Medicine Highlights AI-Driven Roadmap in Longevity Medicine
PremiumPrivate Companies
Insilico Medicine Highlights AI-Driven Roadmap in Longevity Medicine
2d ago
INSIL
FDA Fast Track Milestone Highlights Insilico Medicine’s AI-Driven Oncology Pipeline
PremiumPrivate Companies
FDA Fast Track Milestone Highlights Insilico Medicine’s AI-Driven Oncology Pipeline
2d ago
INSIL
Insilico Medicine Introduces AI Benchmark Service for Drug Discovery
PremiumPrivate Companies
Insilico Medicine Introduces AI Benchmark Service for Drug Discovery
2d ago
INSIL
Insilico Medicine Gains FDA Fast Track, Expands AI Benchmark Services and Highlights New Pain and Respiratory Assets
PremiumPrivate CompaniesInsilico Medicine Gains FDA Fast Track, Expands AI Benchmark Services and Highlights New Pain and Respiratory Assets
5d ago
INSIL
Insilico Medicine Highlights Role in China’s Emerging Biotech and AI Drug Discovery Landscape
Premium
Private Companies
Insilico Medicine Highlights Role in China’s Emerging Biotech and AI Drug Discovery Landscape
5d ago
INSIL
Insilico Medicine Launches AI Benchmark Platform for Drug Discovery Models
Premium
Private Companies
Insilico Medicine Launches AI Benchmark Platform for Drug Discovery Models
6d ago
INSIL
Insilico Medicine Unveils Real-World AI Benchmark Service for Drug Discovery Models
PremiumPrivate Companies
Insilico Medicine Unveils Real-World AI Benchmark Service for Drug Discovery Models
7d ago
INSIL
Insilico Medicine Showcases AI-Driven Drug Development Ambitions at Ai4 2026
PremiumPrivate Companies
Insilico Medicine Showcases AI-Driven Drug Development Ambitions at Ai4 2026
7d ago
INSIL
Insilico Wins FDA Fast Track Status for AI-Designed Mesothelioma Drug ISM6331
PremiumPrivate Companies
Insilico Wins FDA Fast Track Status for AI-Designed Mesothelioma Drug ISM6331
8d ago
INSIL
Insilico Medicine Emphasizes Automated SAR Cliff Analysis in Drug Discovery
PremiumPrivate Companies
Insilico Medicine Emphasizes Automated SAR Cliff Analysis in Drug Discovery
8d ago
INSIL
Insilico Medicine Highlights AI-Discovered Non-Opioid Pain Candidate ISM9528
PremiumPrivate CompaniesInsilico Medicine Highlights AI-Discovered Non-Opioid Pain Candidate ISM9528
8d ago
INSIL
AI-Designed Oncology Candidate From Insilico Medicine Selected for ESMO 2026 Presentation
Premium
Private Companies
AI-Designed Oncology Candidate From Insilico Medicine Selected for ESMO 2026 Presentation
9d ago
INSIL
Insilico Medicine Highlights Phase 3 IPF Program and AI Focus in Respiratory Health Engagement
Premium
Private Companies
Insilico Medicine Highlights Phase 3 IPF Program and AI Focus in Respiratory Health Engagement
9d ago
INSIL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >